普罗帕酮和胺碘酮急诊转复阵发性室上性心动过速的临床对比研究  

Clinical comparison of propafenone and amiodarone in the treatment of paroxysmal supraventricular tachycardia in emergency

作　　者：黄耀旂 Huang Yaoqi(The People's Hospital of Baiyun District,Guangzhou City(Guangdong)510500)

机构地区：[1]广州市白云区人民医院,广东510500

出　　处：《中国社区医师》2018年第22期60-61,共2页Chinese Community Doctors

摘　　要：目的:探讨普罗帕酮和胺碘酮急诊转复阵发性室上性心动过速的效果。方法:收治阵发性室上性心动过速患者75例,分为对照组和试验组。对照组采用普罗帕酮疗法,试验组采用胺碘酮疗法,比对两组治疗结果。结果:两组好转率差异无统计学意义(P>0.05);两组不良反应发生率和平均转复时间差异有统计学意义(P<0.05)。结论:胺碘酮、普罗帕酮治疗阵发性室上性心动过速患者的效果相当,但胺碘酮安全性高,不良反应少。Objective:To explore the clinical effect of propafenone and amiodarone in the treatment of paroxysmal supraventricular tachycardia in emergency.Methods:75 patients with paroxysmal supraventricular tachycardia were selected,they were divided into the control group and the experimental group,the control group was treated with propafenone therapy,and the experimental group was treated with amiodarone therapy,we compared the results of the two groups.Results:There was no significant difference in the improvement rate between the two groups(P>0.05).The incidences of adverse reactions and average conversion time between the two groups were statistically significant(P<0.05).Conclusion:The effect of propafenone and amiodarone in the treatment of paroxysmal supraventricular tachycardia was equivalent,but amiodarone had high safety and few adverse reactions.

关 键 词：阵发性室上性心动过速 普罗帕酮 胺碘酮 

分 类 号：R541.71[医药卫生—心血管疾病]